Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Keros Therapeutics (KROS) Interest Coverage Ratio: 2019-2022

Historic Interest Coverage Ratio for Keros Therapeutics (KROS) over the last 3 years, with Mar 2022 value amounting to -24,126.00.

  • Keros Therapeutics' Interest Coverage Ratio fell 53.00% to -24,126.00 in Q1 2022 from the same period last year, while for Mar 2022 it was -16,182.50, marking a year-over-year decrease of 55.83%. This contributed to the annual value of -114,790.00 for FY2022, which is 714.50% down from last year.
  • Keros Therapeutics' Interest Coverage Ratio amounted to -24,126.00 in Q1 2022, which was down 395.81% from -4,866.00 recorded in Q4 2021.
  • In the past 5 years, Keros Therapeutics' Interest Coverage Ratio registered a high of -775.33 during Q3 2019, and its lowest value of -24,126.00 during Q1 2022.
  • In the last 3 years, Keros Therapeutics' Interest Coverage Ratio had a median value of -13,291.00 in 2020 and averaged -12,881.11.
  • In the last 5 years, Keros Therapeutics' Interest Coverage Ratio crashed by 723.39% in 2020 and then surged by 63.39% in 2021.
  • Quarterly analysis of 4 years shows Keros Therapeutics' Interest Coverage Ratio stood at -775.33 in 2019, then slumped by 670.51% to -13,291.00 in 2020, then spiked by 63.39% to -4,866.00 in 2021, then crashed by 53.00% to -24,126.00 in 2022.
  • Its Interest Coverage Ratio was -24,126.00 in Q1 2022, compared to -4,866.00 in Q4 2021 and -20,197.00 in Q3 2021.